Skip to content

Cognitive-behavioral Treatment for Rheumatoid Arthritis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02257073
Enrollment
150
Registered
2014-10-06
Start date
2014-10-31
Completion date
2020-07-31
Last updated
2017-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Brief summary

To evaluate the effectiveness of Cognitive-behavioral treatment for people with rheumatoid arthritis

Interventions

BEHAVIORALWaiting List

Sponsors

Chengdu PLA General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* diagnosed by rheumatology consultants with RA

Exclusion criteria

* severe psychological difficulties * currently receiving mental health care * any medical condition that might prevent them from safely exercising (e.g. history of more severe heart, lung or cerebrovascular disease) * previously attended an education programme * had a Modified Health Assessment Questionnaire score \>2 (score range 0-3), that is severe functional problems * history of organic brain syndrome * presence of a psychotic disorder * presence of other uncontrolled medical disorders * presence of a major communication disorder, illiteracy * presence of less than an 8th grade education (due to inability to complete questionnaires) * presence of a therapeutic dosage of an antidepressant medication, or presence of another autoimmune disease/disabling condition

Design outcomes

Primary

MeasureTime frame
Changes from baseline in disease activity score in 28 joints(DAS28) at 48 weeksat 0 week, 12 weeks, 24 weeks, 48 weeks

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026